LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 71.54 | 771.67 | 5482 | 10532 | 0.5205 | 0.6820 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 71.54 | 771.67 | 4680 | 10532 | 0.4443 | 0.6129 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 71.54 | 771.67 | 4489 | 10532 | 0.4262 | 0.5952 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 73.76 | 771.67 | 5791 | 10851 | 0.5337 | 0.6964 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 73.76 | 771.67 | 4946 | 10851 | 0.4558 | 0.6276 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 73.76 | 771.67 | 4608 | 10851 | 0.4246 | 0.5977 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.02 | 771.67 | 6007 | 11106 | 0.5408 | 0.7047 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.02 | 771.67 | 5174 | 11106 | 0.4658 | 0.6398 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 76.02 | 771.67 | 4862 | 11106 | 0.4378 | 0.6135 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.25 | 771.67 | 6289 | 11367 | 0.5532 | 0.7171 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.25 | 771.67 | 5401 | 11367 | 0.4751 | 0.6510 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 78.25 | 771.67 | 5025 | 11367 | 0.4420 | 0.6206 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.48 | 771.67 | 6524 | 11685 | 0.5583 | 0.7237 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.48 | 771.67 | 5690 | 11685 | 0.4870 | 0.6646 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 80.48 | 771.67 | 5297 | 11685 | 0.4533 | 0.6345 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.69 | 771.67 | 6706 | 11974 | 0.5601 | 0.7274 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.69 | 771.67 | 5851 | 11974 | 0.4886 | 0.6688 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 82.69 | 771.67 | 5399 | 11974 | 0.4509 | 0.6352 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.92 | 771.67 | 7183 | 12266 | 0.5856 | 0.7490 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.92 | 771.67 | 6275 | 12266 | 0.5116 | 0.6908 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 84.92 | 771.67 | 5770 | 12266 | 0.4704 | 0.6556 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.14 | 771.67 | 7453 | 12592 | 0.5919 | 0.7559 | MN20160304_L01 | D18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.14 | 771.67 | 6522 | 12592 | 0.5179 | 0.6986 | MN20160304_L01 | F14 |
| MCF 10A-H2B-mCherry | Neratinib | 0.1 | 87.14 | 771.67 | 5739 | 12592 | 0.4558 | 0.6456 | MN20160304_L01 | N05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.17783 | 2.49 | 771.67 | 938 | 867 | 1.0810 | 2.1676 | MN20160304_L01 | N06 |